Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelocytic”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT02158858
What this trial is testing

CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Who this might be right for
MyelofibrosisLeukemia, Myelocytic, AcuteMyelodysplastic/Myeloproliferative Neoplasm+11 more
Constellation Pharmaceuticals 336
Early research (Phase 1)Ended earlyNCT01300611
What this trial is testing

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

Who this might be right for
Double Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic Syndrome+6 more
Tarix Pharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Early research (Phase 1)Study completedNCT00854646
What this trial is testing

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelocytic Leukemia+2 more
Traws Pharma, Inc. 22
Large-scale testing (Phase 3)Ended earlyNCT01339910
What this trial is testing

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Who this might be right for
Leukemia, Myelocytic, Acute
Medical College of Wisconsin 272
Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Large-scale testing (Phase 3)Study completedNCT00152139
What this trial is testing

Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiasAcute Myelocytic LeukemiaChronic Myeloid Leukemia+4 more
St. Jude Children's Research Hospital 33
Early research (Phase 1)Ended earlyNCT02255162
What this trial is testing

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myelocytic LeukemiaAcute Myelogenous Leukemia+2 more
Massachusetts General Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00067002
What this trial is testing

Randomized Double Cord Blood Transplant Study

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myelocytic, AcuteLeukemia, Myeloid, Chronic+1 more
M.D. Anderson Cancer Center 110
Testing effectiveness (Phase 2)Study completedNCT01723657
What this trial is testing

Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myelocytic, Acute
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 862
Not applicableStudy completedNCT00286845
What this trial is testing

Use of the MiCK Assay for Apoptosis in AML

Who this might be right for
Leukemia, Myelocytic, Acute
Pierian Biosciences 50
Early research (Phase 1)Ended earlyNCT02177812
What this trial is testing

A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 41
Testing effectiveness (Phase 2)Study completedNCT00061581
What this trial is testing

Experimental Bone Marrow Transplant Protocol

Who this might be right for
Acute Lymphocytic LeukemiaChronic Myeloid LeukemiaAcute Myelocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 14
Testing effectiveness (Phase 2)UnknownNCT00126321
What this trial is testing

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

Who this might be right for
Leukemia, Myelocytic, Acute
University Hospital, Bonn 50
Post-approval studies (Phase 4)Study completedNCT00304447
What this trial is testing

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteInfusions, Intravenous
Wyeth is now a wholly owned subsidiary of Pfizer 30
Early research (Phase 1)Study completedNCT01607892
What this trial is testing

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Who this might be right for
Hematological Malignancies
Karyopharm Therapeutics Inc 286
Early research (Phase 1)Study completedNCT00502385
What this trial is testing

Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML

Who this might be right for
LeukaemiaMyelocyticAcute
AstraZeneca 54
Early research (Phase 1)Study completedNCT00251368
What this trial is testing

Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteAcute Lymphocytic Leukemia
Dana-Farber Cancer Institute 52
Testing effectiveness (Phase 2)Study completedNCT01716793
What this trial is testing

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Myelocytic, Acute
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 354
Testing effectiveness (Phase 2)Looking for participantsNCT06420063
What this trial is testing

Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML

Who this might be right for
AMLAcute Myeloid LeukemiaAML, Adult Recurrent+1 more
Essen Biotech 85
Load More Results